RS

Richa Sharma

Active Director Director DIN 10448469
DIN 10448469 First appointment Dec 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About Richa Sharma

Data last updated:

Richa Sharma is a Director at Welwart Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Welwart Pharmaceuticals Private Limited reported revenue of ₹1.56 Cr (FY 2025).

DIN 10448469
Primary Designation Director
Industry Pharma
First Appointment 28 Dec 2023
Oldest Company Age 5 yrs
Largest company Welwart Pharmaceuticals Private Limited · ₹1.56 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Dec 20232021₹1.56 Cr (FY 2025)Active

Board colleagues of Richa Sharma

Directorship timeline

Open interactive timeline →
Welwart Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Richa Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Richa Sharma

Richa Sharma currently holds 1 directorship: Welwart Pharmaceuticals Private Limited (Director, since 28 Dec 2023, revenue ₹1.56 Cr (FY 2025)).

Richa Sharma was first appointed on 28 Dec 2023 as Director at Welwart Pharmaceuticals Private Limited.

The current boards of Richa Sharma's companies include Anuj Kumar (Welwart Pharmaceuticals Private Limited), Asha Sharma (Welwart Pharmaceuticals Private Limited), Kajal Tyagi (Welwart Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available